Auspex Pharmaceuticals, Inc.
DelistedCIK 1454189fmd_0XVJ01N3FT9V0M2RF27VC3YC2SManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2012 to Dec 31, 2014, 9 periods
| Line item | FY2012 | FY2013 | FY2014 |
|---|---|---|---|
| Research and development | 12 | 10 | 38 |
| Total operating expenses | 13 | 13 | 50 |
| Operating income | (13) | (13) | (50) |
| Interest expense | 1 | 0 | 3 |
| Interest and investment income | 0 | – | 1 |
| Other non-operating income (expense) | (2) | (2) | (9) |
| Income tax expense | – | – | 0 |
| Net income | (15) | (16) | (60) |